Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer

Journal of Pain and Symptom Management

Volumn 19, Issue 6, 2000, Pages 436-445

  Stein, Kevin D ^a   Jacobsen, Paul B ^a   Hann, Danette M ^b   Greenberg, Harvey ^a   Lyman, Gary ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b BEHAVIORAL RESEARCH CENTER   (United States)

Author keywords

Breast cancer; Fatigue; Hot flashes; Quality of life

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; MITOXANTRONE;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CHEMOTHERAPY; CLINICAL TRIAL; DISEASE SEVERITY; FATIGUE; FEMALE; HEALTH; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SELF REPORT; SLEEP;

AGED; BREAST NEOPLASMS; FEMALE; FLORIDA; GEORGIA; HOT FLASHES; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PREVALENCE; QUALITY OF LIFE;

EID: 0033949198     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(00)00142-1     Document Type: Article

References (24)

1. Kronenberg F. Hot flashes. epidemiology and physiology Ann NY Acad Sci. 592:1990;52-86.
2. Couzi R.J., Helzlsouer K.J., Fetting J.H. Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J Clin Oncol. 13:1995;2737-2744.
3. Carpenter J.S., Andrykowski M.A., Cordova M., Cunningham L., Studts J., McGrath P.et al. Hot flashes in postmenopausal women treated for breast cancer. prevalence, severity, correlates, management, and relation to quality of life Cancer. 82:1998;1682-1691.
4. Ravnikar V. Physiology and treatment of hot flashes. Obstet Gynecol. 75(Suppl 3):1990;3S-7S.
5. Dupont W., Page D. Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med. 151:1991;67-72.
6. Steinberg K.K., Thacker S.B., Smith J.et al. A meta-analysis of the effect of estrogen replacement therapy and the risk of breast cancer. JAMA. 265:1991;1985-1990.
7. Ingle J.N., Mailliard J.A., Schaid D.J., Krook J.E., Gesme D.H., Windschitl H.E.et al. A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausl women with metastatic breast cancer. Cancer. 68:1991;34-39.
8. Ware J.E., Snow K.K., Kosinski M., Gandek B. SF-36 Health Survey. manual and interpretation guide:1993;New England Medical Center, Boston, MA.
9. Portenoy R.K., Thaler H.T., Kornblith A.B.et al. The Memorial Symptom Assessment Scale. An instrument for the evaluation of symptom prevalence, characteristics and distress Eur J Cancer. 30A:1994;1326-1336.
10. Spielberger C.D., Gorsuch R.L., Lushene R.D. STAI. Manual for the State-Trait Anxiety Inventory:1970;Consulting Psychologists Press, Palo Alto, CA.
11. Spielberger C.D. State-Trait Anxiety Inventory for Adults. 1983;Consulting Psychological Press, Palo Alto, CA.
12. Radloff L.S. The CES-D Scale. a self-report depression scale for research in the general population Appl Psycho Meas. 1:1977;385-401.
13. Radloff L.S., Teri L. Use of the Center for Epidemiologic Studies-Depression Scale with older adults. Brink T.L. Clinical Gerontology. A Guide to Assessment and Intervention:1986;119-135 Haworth Press, New York.
14. Beeber L.S., Shea J., McCorkle R. The Center for Epidemiologic Studies Depression Scale as a measure of depressive symptoms in newly diagnosed patients. J Psychosoc Oncol. 16:1998;1-20.
15. McNair D.M., Lorr M., Droppleman L.F. The Manual for the Profile of Mood States. 1981;Educational and Industrial Testing Service, San Diego, CA.
16. Winningham M.L., Nail L.M., Burke M.B.et al. Fatigue and the cancer experience. The state of knowledge Oncol Nurs Forum. 21:1994;23-36.
17. Hann D., Jacobsen P.B., Azzarello L.M.et al. Measurement of fatigue in cancer patients. development and validation of the Fatigue Symptom Inventory Qual Life Res. 7:1998;301-310.
18. Broeckel J.A., Jacobsen P.B., Horton J., Balducci L., Lyman G.H. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol. 16:1998;1689-1696.
19. Stein K.D., Martin S.C., Hann D.M.et al. Construction of a multidimensional measure of fatigue for clinical use with cancer patients. Cancer Prac. 6:1998;143-152.
20. Buysse D.J., Reynolds C.F., Monk T.H.et al. The Pittsburgh Sleep Quality Index. a new instrument for psychiatric practice and research Psychiatry Res. 28:1988;193-213.
21. Love R.R., Cameron L., Connell B.L., Leventhal H. Symptoms associated with tamoxifen treatment in postmenopausal women. Arch Intern Med. 151:1991;1842-1847.
22. Barton D.L., Loprinzi C.L., Quella S.K., Sloan J.A., Veeder M.H., Egner J.R.et al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol. 16:1998;495-500.
23. Loprinzi C.L., Pisansky T.M., Fonseca R., Sloan J.A., Zahasky K.M., Quella S.K.et al. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J Clin Oncol. 16:1998;2377-2381.
24. Quella S.K., Loprinzi C.L., Sloan J.A., Vaught N.L., DeKrey W.L., Fischer T.et al. Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes. Cancer. 82:1998;1784-1788.